Skip to Main Content

Yale Clinical and Epidemiology Research in Neurology (CERN) Training Program (T32)

Yale University offers a new postdoctoral program in clinical, translational and epidemiologic research in neurology, sponsored by the National Institute of Neurologic Diseases and Stroke. The training program provides highly qualified fellows (MDs or PhDs) with opportunities to expand their skills in neuroepidemiology, clinical research, and translational investigation, and to embark upon an intensive research experience under the mentorship of experienced investigators who specialize in research investigation in neurological disease and brain health.

Highlights of the program include:

  • 2 years of protected research time to pursue independently in collaborative aging research projects.
  • Dedicated mentorship from internationally recognized leaders in clinical and translational neuroscience research.
  • Opportunity to combine research training experience with concurrent clinical subspecialty fellowship at Yale (must be coordinated with/approved by subspecialty fellowship director).
  • Access to resources and support from the extensive faculty and programs at the Yale School of Medicine, Yale School of Public Health, and Yale University more broadly.
  • Salary support and benefit coverage during the two-year duration of the T32, with additional stipend coverage for participation in conferences and workshops outside of Yale to support the educational experience.
  • Tuition coverage to take two courses per semester at the Yale School of Public Health in biostatistics, epidemiology, study design, bioinformatics, and related disciplines.
  • The program seeks MDs and PhDs (in neurology, epidemiology, biostatistics, psychology, biology, and other relevant disciplines) who are committed to an academic career in neurology-related research. Candidates from underrepresented groups are strongly encouraged to apply. US citizenship or permanent residence is required.
Application deadline for July 1, 2021 start date is: February 1, 2021.

For more information, please contact Dr. Serena Spudich, MD (